4.8 Article

Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression

Journal

MOLECULAR PSYCHIATRY
Volume 23, Issue 1, Pages 133-142

Publisher

SPRINGERNATURE
DOI: 10.1038/mp.2017.44

Keywords

-

Funding

  1. Wellcome Trust [102215/2/13/2]
  2. UK Medical Research Council [MC_UU_12013/6, G9502233, G0300128, C865/A2883, G120/635]
  3. ALSPAC
  4. Leverhulme Trust
  5. British Heart Foundation
  6. Cancer Research UK
  7. Economic and Social Research Council
  8. Medical Research Council
  9. National Institute for Health Research under UK Clinical Research
  10. Australian Research Council [DP130101459, DP160103160, APP1082406]
  11. National Health and Medical Research Council of Australia
  12. CHDS from the Health Research Council of New Zealand [HRC 11/792]
  13. CoFaMS [APP1060524]
  14. COGA from the National Institutes of Health, NIAAA [U10AA008401]
  15. NIDA
  16. COGEND: National Institutes of Health from NCI [P01CA089392]
  17. NIDA [R01DA036583]
  18. DeCC from the UK Medical Research Council [G0701420]
  19. UK MRC Population Health Scientist [G1002366]
  20. EPIC-Norfolk from the UK Medical Research Council [G9502233, G0300128, C865/A2883]
  21. Novartis
  22. National Research Agency (ANR) [07 LVIE004]
  23. WT Grant Foundation
  24. National Institute for Health Research (NIHR) Biomedical Research Centre at South London
  25. Maudsley NHS Foundation Trust
  26. King's College London
  27. PHRC UF from CHU Montpellier & Agence Nationale de la Recherche [7653]
  28. ANR NEURO 'GENESIS' from CHU Montpellier & Agence Nationale de la Recherche
  29. German Research Foundation (DFG) [LA 733/2-1]
  30. Federal Ministry for Education and Research as part of the ' National Genome Research Network'
  31. National Institutes of Health [R01 AA07065, NIH R01 HD042157-01A1, MH081802, 1RC2 MH089951, 1RC2 MH089995]
  32. NIAAA [R37 AA07065]
  33. European Union [EU-FP7HEALTH-F2-2008-222963]
  34. FOR from the German Research Foundation (DFG) [DA1151/5-1]
  35. Sixth Framework Program of the European Union [LSHM-CT-2004-503474]
  36. National Development Agency Hungarian Brain Research Program [KTIA_ NAP_ 13-1-2013-0001, KTIA_ 13_ NAP-A-II/14]
  37. MTA-SE-NAP B Genetic Brain Imaging Migraine Research Group, Hungarian Academy of Sciences, Semmelweis University [KTIA_ NAP_ 13-2-2015-0001]
  38. Hungarian Academy of Sciences
  39. MTA-SE Neuropsychopharmacology and Neurochemistry Research Group
  40. National Institute for Health Research Manchester Biomedical Research Centre
  41. MagW/ZonMW [Middelgroot-911-09-032, Spinozapremie 56-46414192]
  42. Netherlands Organization for Health Research and Development [ZonMW 10-000-1002]
  43. Genetic influences on stability and change in psychopathology from childhood to young adulthood [ZonMW 912-10-020]
  44. NBIC/BioAssist/RK [2008.024]
  45. Biobanking and Biomolecular Resources Research Infrastructure (BBMRI -NL) [184.021.007]
  46. European Science Council (ERC) [230374]
  47. Genetic Association Information Network (GAIN) of the Foundation for the National Institutes of Health
  48. Rutgers University Cell and DNA Repository [NIMH U24 MH068457-06]
  49. Avera Institute (USA)
  50. Sioux Falls (USA)
  51. South Dakota (USA)
  52. National Health and Medical Research Council of Australia [179805, 941177, 971232, 339450, 443011]
  53. Perinatal Epidemiologic Research Initiative Program Grant from the March of Dimes Foundation [20FY01-38, 20-FY04-37]
  54. National Institutes of Health from NICHD [R01 HD34543]
  55. NINR
  56. Thrasher Research Foundation [02816-7]
  57. Centers for Disease Control and Prevention [U01 DP000143-01]
  58. US Public Health Service [AA07535, AA07728, AA10249]
  59. National Institutes of Health from NIDA [K99DA023549-01A2, R21 DA033827, R01 DA026911]
  60. Beyond Blue
  61. Brain Foundation (Hjarnfonden) [FO2012-0326, FO2013-0023, FO2014-0243]
  62. Soderstrom-Konigska Foundation [SLS-559921]
  63. Swedish Council for Working Life and Social Research [2015-00897]
  64. Ake Wiberg's Foundation [M15-0239]
  65. Systembolagets Rad for Alkoholforskning
  66. SRA
  67. Svenska Spel Research Council
  68. National Institutes of Health from NIA [R01 AG16790, R01 AG16661, R56 AG01661]
  69. NICHD [P2CHD047879]
  70. Graduate School of Arts and Sciences at Georgetown University
  71. German Federal Ministry of Education and Research [01ZX1314E]
  72. Federal Ministry of Education and Research [01ZZ9603, 01ZZ0103, 01ZZ0403, 03ZIK012, 03IS2061A]
  73. Ministry of Cultural Affairs
  74. Social Ministry of the Federal State of Mecklenburg-West Pomerania
  75. Siemens Healthcare, Erlangen, Germany
  76. Federal State of Mecklenburg-West Pomerania
  77. German Research Foundation [GR 1912/5-1]
  78. GB-MW [94038- 011]
  79. ZonMW [100-001-004]
  80. GBMaGW [480-07-001]
  81. Netherlands Organization for Scientific Research (NWO) [481-08-013]
  82. Dutch Ministry of Justice
  83. European Science Foundation
  84. BBMRINL
  85. UMCG
  86. RUG
  87. Erasmus MC
  88. UU
  89. Radboud MC
  90. Parnassia Bavo group
  91. Australia's National Health and Medical Research Council of Australia (NHMRC) [APP1063091, 1008271, 1019887]
  92. National Institutes of Health from NIDA
  93. [175.010.2003.005]
  94. Medical Research Council [G120/635, MC_UU_12013/6, G9815508, G1002366, MC_UU_00011/7, MC_PC_15018] Funding Source: researchfish
  95. MQ: Transforming Mental Health [MQ14F40] Funding Source: researchfish
  96. MRC [G1002366, G120/635, G0701420, MC_UU_12013/6, MC_UU_00011/7] Funding Source: UKRI
  97. EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER
  98. EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034543, R01HD042157] Funding Source: NIH RePORTER
  99. NATIONAL CANCER INSTITUTE [P01CA089392] Funding Source: NIH RePORTER
  100. NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U01DP000143] Funding Source: NIH RePORTER
  101. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079235] Funding Source: NIH RePORTER
  102. NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089951, RC2MH089995, R01MH081802, U24MH068457] Funding Source: NIH RePORTER
  103. NATIONAL INSTITUTE ON AGING [P50AG005138, R01AG016661, R01AG016790] Funding Source: NIH RePORTER
  104. NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA007728, R37AA007065, R01AA007065, R37AA007728, U10AA008401, R01AA010249, R01AA007535] Funding Source: NIH RePORTER
  105. NATIONAL INSTITUTE ON DRUG ABUSE [R21DA033827, K99DA023549, R01DA036583, R01DA026911] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The hypothesis that the S allele of the 5-HTTLPR serotonin transporter promoter region is associated with increased risk of depression, but only in individuals exposed to stressful situations, has generated much interest, research and controversy since first proposed in 2003. Multiple meta-analyses combining results from heterogeneous analyses have not settled the issue. To determine the magnitude of the interaction and the conditions under which it might be observed, we performed new analyses on 31 data sets containing 38 802 European ancestry subjects genotyped for 5-HTTLPR and assessed for depression and childhood maltreatment or other stressful life events, and meta-analysed the results. Analyses targeted two stressors (narrow, broad) and two depression outcomes (current, lifetime). All groups that published on this topic prior to the initiation of our study and met the assessment and sample size criteria were invited to participate. Additional groups, identified by consortium members or self-identified in response to our protocol (published prior to the start of analysis) with qualifying unpublished data, were also invited to participate. A uniform data analysis script implementing the protocol was executed by each of the consortium members. Our findings do not support the interaction hypothesis. We found no subgroups or variable definitions for which an interaction between stress and 5-HTTLPR genotype was statistically significant. In contrast, our findings for the main effects of life stressors (strong risk factor) and 5-HTTLPR genotype (no impact on risk) are strikingly consistent across our contributing studies, the original study reporting the interaction and subsequent meta-analyses. Our conclusion is that if an interaction exists in which the S allele of 5-HTTLPR increases risk of depression only in stressed individuals, then it is not broadly generalisable, but must be of modest effect size and only observable in limited situations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available